New hope for advanced cervical cancer: drug combo aims to extend survival
NCT ID NCT07392060
First seen Feb 06, 2026 · Last updated May 17, 2026 · Updated 8 times
Summary
This study tests whether a new combination of two drugs (WX390 and toripalimab) can help people with advanced cervical cancer that has come back or spread and no longer responds to standard platinum chemotherapy. About 440 adults aged 18 to 75 will be randomly assigned to receive either the new combo or another treatment chosen by their doctor. The main goal is to see if the combo helps people live longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.